Rafferty Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
Rafferty Asset Management's EBS Position: Q3 2026 in Review
Rafferty Asset Management increased its Emergent Biosolutions (EBS) stake by 48% in Q3 2026, buying an estimated $149K and bringing the position to 70,128 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #905.
Rafferty Asset Management first reported a position in EBS in Q1 2019 and has held it in 27 quarters since. The position peaked at $6.02M in Q1 2022. 187 funds tracked by Wall St. Rank hold EBS as of Q3 2026.
- Rafferty Asset Management held 70,128 shares of Emergent Biosolutions worth $463K as of Q3 2026.
- Rafferty Asset Management bought 22,698 Emergent Biosolutions shares in Q3 2026, an estimated $149K.
- Emergent Biosolutions made up ﹤0.01% of Rafferty Asset Management's portfolio in Q3 2026, its #905 holding.
- Rafferty Asset Management first reported a position in Emergent Biosolutions in Q1 2019 and has held it in 27 quarters since.
- Rafferty Asset Management's Emergent Biosolutions position peaked at $6.02M in Q1 2022.
- 187 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2026.
Based on Rafferty Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.